Two thiazolylindoles and a benzimidazole: Novel compounds on the designer drug market with potential cannabinoid receptor activity

Forensic Science International

Volumn 249, Issue , 2015, Pages 133-147

  Westphal, Folker ^a   Sönnichsen, Frank D ^b   Knecht, Siegfried ^c   Auwärter, Volker ^d   Huppertz, Laura ^d  

^a State Bureau of Criminal Investigation Schleswig Holstein   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Laboratory Frankfurt   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

3 ( 1,3 thiazol 2 yl)indole; Analytical data; Benzimidazole; Cannabimimetic; Structure elucidation

Indexed keywords

1 (CYCLOHEXYLMETHYL) 2 [(4 ETHOXYPHENYL)METHYL] N,N DIETHYL 1H BENZIMIDAZOLE 5 CARBOXAMIDE; BENZIMIDAZOLE DERIVATIVE; CANNABINOID RECEPTOR; DESIGNER DRUG; INDOLE DERIVATIVE; N (2 METHOXYETHYL),N ISOPROPYL 2 (1 PENTYL 1H INDOL 3 YL) 4 THIAZOLEMETHANAMINE; N,N DIETHYL 2 (1 PENTYL 1H INDOL 3 YL) 4 THIAZOLEMETHANAMINE; UNCLASSIFIED DRUG; BENZIMIDAZOLE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; THIAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CONTROL; DRUG MARKETING; DRUG TRAFFIC; ELECTROSPRAY MASS SPECTROMETRY; GERMANY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; CHEMISTRY; GAS CHROMATOGRAPHY; HUMAN; INFRARED SPECTROPHOTOMETRY; MASS SPECTROMETRY;

BENZIMIDAZOLES; CHROMATOGRAPHY, GAS; DESIGNER DRUGS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SPECTROPHOTOMETRY, INFRARED; THIAZOLES;

EID: 84923008577     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2015.01.014     Document Type: Article

References (22)

1. Uchiyama N., Matsuda S., Kawamura M., Shimokawa Y., Kikura-Hanajiri R., Aritake K., Urade Y., Goda Y. Characterization of four new designer drugs, 5-chloro-NNEI NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci. Int. 2014, 243C:1-13.
2. Dresen S., Ferreirós N., Pütz M., Westphal F., Zimmermann R., Auwärter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45(10):1186-1194.
3. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci. Int. 2013, 227(1-3):21-32.
4. Westphal F., Girreser U., Knecht S. Structure elucidation of a new open chain isomer of the cannabimimetic cyclopropoylindole A-796,260. Forensic Sci. Int. 2014, 234:139-148.
5. Kikura-Hanajiri R., Kawamura N.U., Goda Y. Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test Anal. 2014, 6(7-8):832-839.
6. Kneisel S., Westphal F., Bisel P., Brecht V., Broecker S., Auwärter V. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'. J. Mass Spectrom. 2012, 47(2):195-200.
7. Moosmann B., Kneisel S., Girreser U., Brecht V., Westphal F., Auwärter V. Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS NMR analysis and a flash chromatography system. Forensic Sci. Int. 2012, 220(1-3):e17-e22.
8. Uchiyama N., Matsuda S., Kawamura M., Kikura-Hanajiri R., Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013, 31(2):223-240.
9. European Drug Report 2014: Trends and Developments 2014, May, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon. http://www.emcdda.europa.eu/attachements.cfm/att_228272_DE_TDAT14001DEN.pdf.
10. Dawson P.H., Sun W.F. A round robin on the reproducibility of standard operating conditions for the acquisition of library MS/MS spectra using triple quadrupols. Int. J. Mass Spectrom. Ion Proc. 1984, 55:155-170.
11. + immonium ions. J. Mass Spectrom. 1996, 31:1047-1053. For production spectrometry of immonium ions for structure elucidation see:, T. Junge, P. Rösner, F. Westphal, Product ion mass spectra of important organic ions, a free printed version can be ordered from the authors.
12. Westphal F., Junge T., Sönnichsen F., Rösner P., Schäper J. Ein neuer Wirkstoffin SPICE-artigen Kräutermischungen: Charakterisierung von JWH-250, seinen Methyl- und Trimethylsilyderivaten (A new active compound in SPICE-like products: characterization of JWH-250, it's methyl- and trimethylsilyl derivatives). Toxichem Krimtech 2010, 77/1:46-58.
13. Ernst L., Schiebel H.-M., Theuring C., Lindigkeit R., Beuerle T. Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incences. Forensic Sci. Int. 2011, 208:e31-e35.
14. Jankovics P., Váradi A., Tölgyesi L., Lohner S., Németh-Palotás J. Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary. Forensic Sci. Int. 2012, 214:27-32.
15. Harris D.N., Hokanson S., Miller V., Jackson G.P. Fragmentation differences in the EI spectra of three synthetic cannabinoid positional isomers: JWH-250 JWH-302, and JWH-201. Int. J. Mass Spectrom. 2014, 368:23-29.
16. 1 receptor. Bioorg. Med. Chem. Lett. 2011, 21:506-509.
17. J. Adam-Worrall, A.J. Morrison, G. Wishart, T. Kiyoi, R.D. McArthur, Patent WO 2005/089754 A1.
18. J. Adam-Worrall, A.J. Morrison, G. Wishart, T. Kiyoi, D.R. McArthur, Patent US 7,700,634 B3, 2010.
19. Pagé D., Balaux E., Boisvert L., Liu Z., Milburn C., Tremblay M., Wei Z., Woo S., Luo X., Cheng Y.-X., Yang H., Srivastava S., Zhou F., Brown W., Tomaszewski M., Walpole C., Hodzic L., St-Onge S., Godbout C., Salois D., Payza K. Novel benzimidazole derivatives as selective CB2 agonists. Bioorg. Med. Chem. Lett. 2008, 18:3695-3700.
20. Ratcliffe P., Adam J.M., Baker J., Bursi R., Campbell R., Clarke J.K., Cottney J.E., Deehan M., Easson A.-M., Ecker D., Edwards D., Epemolu O., Evans L., Fields R., Francis S., Harradine P., Jeremiah F., Kiyoi T., McArthur D., Morrison A., Passier P., Pick J., Schnabel P.G., Schulz J., Steinbrede H., Walker G., Westwood P., Wishart G., Udo de Haes J. Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate. Bioorg. Med. Chem. Lett. 2011, 21:2541-2546.
21. Cichero E., Cesarini S., Mosti L., Fossa P. CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists. J. Mol. Model. 2010, 16(9):1481-1498.
22. Mella-Raipán J.A., Lagos C.F., Recabarren-Gajardo G., Espinosa-Bustos C., Romero-Parra J., Pessoa-Mahana H., Iturriaga-Vásquez P., Pessoa-Mahana C.D. Design, synthesis, binding and docking-based 3D-QSAR studies of 2-pyridylbenzimidazoles - a new family of high affinity CB1 cannabinoid ligands. Molecules 2013, 18:3972-4001.